Catalyst Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 2,567 | 0.0% | 109,999 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 2,169 | 0.0% | 110,099 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 2,154 | 0.0% | 99,257 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 2,383 | 0.0% | 98,265 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 2,092 | 0.0% | 100,230 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 2,007 | 0.0% | 100,957 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 1,622 | 0.0% | 104,707 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 1,695 | 0.0% | 106,357 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 1,715 | 0.0% | 102,011 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 1,304 | 0.0% | 111,569 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 1,618 | 0.0% | 120,397 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 2,039 | 0.0% | 122,951 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 2,301 | 0.0% | 123,730 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 1,563 | 0.0% | 121,855 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 875 | 0.0% | 124,821 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 1,034 | 0.0% | 124,727 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 917 | 0.0% | 135,492 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 703 | 0.0% | 132,626 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 772 | 0.0% | 134,176 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 683 | 0.0% | 148,178 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 487 | 0.0% | 145,751 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 433 | 0.0% | 145,751 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 673 | 0.0% | 145,694 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 561 | 0.0% | 145,694 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 564 | 0.0% | 150,315 | 12/31/2019 |